WASHINGTON — The Food and Drug Administration has lifted its clinical hold on ... combination shot and flu vaccine to drive future growth. Novavax's traditional protein-based COVID shot offers ...

The clinical hold does not impact Novavax's COVID-19 vaccine. The big picture: Pfizer and BioNTech's effort to develop a ...

WASHINGTON — The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID ... FDA to resolve the clinical hold on the trial of its combination shot and the standalone ...

FDA places a clinical hold on Novavax's COVID-19-influenza vaccine trials due to a serious adverse event in a Phase 2 participant. Novavax's COVID-19 IND and European approval for its updated ...

Shares of Novavax (NASDAQ:NVAX) fell roughly 30% Wednesday morning after the U.S. FDA put a clinical hold on the new drug application of its COVID-19 and influenza combination vaccine and ...

The COVID-19 IND for Novavax’s COVID-19 vaccine is not impacted by the clinical hold,” the company stated. “We are working closely with the FDA to provide the necessary information that will ...

Shares in Novavax fell ... of its combination vaccine for COVID-19 and influenza as well as of its standalone flu shots, according to a securities filing. The FDA’s hold, which Novavax was ...

Novavax's combo and standalone flu vaccines showed strong immune responses and good safety in a Phase 3 trial of adults 65 ...

Nov 11 (Reuters) - The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's (NVAX.O), opens new tab COVID-influenza ... shot and flu vaccine to drive ...

Novavax (NASDAQ:NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational new drug application for the pharma firm’s COVID-19-Influenza ...

US FDA Pauses Novavax's Trial of Combo COVID-Flu Shot on Safety Concerns By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration has put on hold a trial of Novavax's COVID-influenza and ...